{
    "root": "361f9f34-f186-da49-e063-6394a90a3d51",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Gabapentin",
    "value": "20250527",
    "ingredients": [
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "XYLITOL",
            "code": "VCQ006KQ1E"
        },
        {
            "name": "GABAPENTIN",
            "code": "6CW7F3G59X"
        }
    ],
    "indications": "Gabapentin Oral Solution is indicated for:\n                  \n                     Management of postherpetic neuralgia in adults\n                     Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy",
    "contraindications": "•Postherpetic Neuralgia ( 2.1) •Dose can be titrated up as needed to a dose of 1800 mg/day •Day 1: Single 300 mg dose •Day 2: 600 mg/day (i.e., 300 mg two times a day) •Day 3: 900 mg/day (i.e., 300 mg three times a day) •Epilepsy with Partial Onset Seizures ( 2.2) •Patients 12 years of age and older: starting dose is 300 mg three times daily; may be titrated up to 600 mg three times daily. •Patients 3 to 11 years of age: starting dose range is 10 to 15 mg/kg/day, given in three divided doses; recommended dose in patients 3 to 4 years of age is 40 mg/kg/day, given in three divided doses; the recommended dose in patients 5 to 11 years of age is 25 to 35 mg/kg/day, given in three divided doses. The recommended dose is reached by upward titration over a period of approximately 3 days •Dose should be adjusted in patients with reduced renal function ( 2.3, 2.4)",
    "warningsAndPrecautions": "Gabapentin Oral Solution is supplied as follows:\n                  250 mg per 5 mL oral solution:\n                  \n                     Clear colorless to slightly yellow solution; each 5 mL of oral solution contains 250 mg of gabapentin; available in: \n     Bottles containing 470 mL: NDC 42192-608-16\n  \n                  \n                  NDC 17856-0600-02 GABAPENTIN 300MG/6ML - 6 ML CUP 72 ct UD *REFRIGERATED\n                  NDC 17856-0600-01 GABAPENTIN 250MG/5ML - 5 ML CUP 72 ct UD * REFRIGERATED\n                  NDC 17856-0600-03 GABAPENTIN 100MG/2ML - 2 ML SYRINGE 120 ct UD * REFRIGERATED",
    "adverseReactions": "Gabapentin Oral Solution is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients."
}